a Centre for Heart and Lung Innovation , St. Paul's Hospital & University of British Columbia , Vancouver , BC , Canada.
b Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine , Dongguk University Ilsan Hospital , Goyang , South Korea.
Expert Rev Respir Med. 2019 Apr;13(4):369-380. doi: 10.1080/17476348.2019.1580576. Epub 2019 Feb 21.
The prevalence of chronic obstructive pulmonary disease (COPD) increases exponentially with aging. Its pathogenesis, however, is not well known and aside from smoking cessation, there are no disease-modifying treatments for this disease. Areas covered: COPD is associated with accelerating aging and aging-related diseases. In this review, we will discuss the hallmarks of aging including genomic instability, telomere attrition, epigenetic alteration, loss of proteostasis, mitochondrial dysfunction, deregulated nutrient sensing, cellular senescence, stem cell exhaustion, and altered intercellular communication, which may be involved in COPD pathogenesis. Expert commentary: COPD and the aging process share similar molecular and cellular changes. Aging-related molecular pathways may represent novel therapeutic targets and biomarkers for COPD.
慢性阻塞性肺疾病(COPD)的患病率随年龄呈指数增长。然而,其发病机制尚不清楚,除了戒烟,目前尚无针对这种疾病的疾病修正治疗方法。
COPD 与加速衰老和与衰老相关的疾病有关。在这篇综述中,我们将讨论衰老的特征,包括基因组不稳定性、端粒磨损、表观遗传改变、蛋白质稳态丧失、线粒体功能障碍、营养感应失调、细胞衰老、干细胞衰竭和细胞间通讯改变,这些可能与 COPD 的发病机制有关。
COPD 和衰老过程具有相似的分子和细胞变化。与衰老相关的分子途径可能代表 COPD 的新的治疗靶点和生物标志物。